Key facts
- This page summarizes Akshay Vaishnaw's Form 4 filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY).
- 8 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Aug 2023, 18:04.
Akshay Vaishnaw - 03 Aug 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)
- Reporting relationship
- President
- Issuer ticker
- ALNY
- Reported as of
- 03 Aug 2023
- Net transaction value
- -$753,986
- SEC form
- 4
- Accepted by SEC
- 07 Aug 2023, 18:04:22 UTC
- Prior SEC filing
- 22 Jun 2023
- Next SEC filing
- 03 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- By: Stephen Hall, Attorney-in-Fact For: Akshay K. Vaishnaw
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Akshay Vaishnaw filed Form 4 for ALNYLAM PHARMACEUTICALS, INC. (ALNY) on 07 Aug 2023.
Change
- Previous filing in this sequence was filed on 22 Jun 2023.
- Current net transaction value: -$753,986.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALNY
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,082
- Change %
- +28%
- Price
- $0.000000
- Shares after
- 22,972
- Date
- 03 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
ALNY
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,859
- Change %
- +17%
- Price
- $0.000000
- Shares after
- 26,831
- Date
- 03 Aug 2023
- Ownership
- Direct
- Footnotes
- F2
ALNY
transaction
Common Stock
Sale
- Transaction value
- -$142,404
- Shares
- -771
- Change %
- -2.9%
- Price
- $184.70
- Shares after
- 26,060
- Date
- 04 Aug 2023
- Ownership
- Direct
- Footnotes
- F3, F4
ALNY
transaction
Common Stock
Sale
- Transaction value
- -$346,774
- Shares
- -1,869
- Change %
- -7.2%
- Price
- $185.54
- Shares after
- 24,191
- Date
- 04 Aug 2023
- Ownership
- Direct
- Footnotes
- F3, F5
ALNY
transaction
Common Stock
Sale
- Transaction value
- -$206,334
- Shares
- -1,107
- Change %
- -4.6%
- Price
- $186.39
- Shares after
- 23,084
- Date
- 04 Aug 2023
- Ownership
- Direct
- Footnotes
- F3, F6
ALNY
transaction
Common Stock
Sale
- Transaction value
- -$18,924
- Shares
- -101
- Change %
- -0.44%
- Price
- $187.37
- Shares after
- 22,983
- Date
- 04 Aug 2023
- Ownership
- Direct
- Footnotes
- F3, F7
ALNY
transaction
Common Stock
Sale
- Transaction value
- -$3,203
- Shares
- -17
- Change %
- -0.07%
- Price
- $188.40
- Shares after
- 22,966
- Date
- 04 Aug 2023
- Ownership
- Direct
- Footnotes
- F8, F9
ALNY
transaction
Common Stock
Sale
- Transaction value
- -$36,348
- Shares
- -192
- Change %
- -0.84%
- Price
- $189.31
- Shares after
- 22,774
- Date
- 04 Aug 2023
- Ownership
- Direct
- Footnotes
- F3
ALNY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 515
- Date
- 03 Aug 2023
- Ownership
- by Managed Account
- Footnotes
- F10
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 10 footnotes
Footnote F1
On February 26, 2020, the reporting person was granted performance-based stock units (PSUs) in connection with the issuer 2019 year-end compensation review. The PSUs vest in separate installments based on the achievement of three specified performance measures as determined by the People, Culture and Compensation Committee of the issuer Board of Directors. The shares reported were issued to the reporting person upon vesting of one-third of the PSUs based on achievement of a corresponding performance measure relating to the issuer public reporting of the achievement of the first $2.5 billion in cumulative net product revenues determined in accordance with GAAP based solely upon the sales by the Company, including its affiliates and ex-U.S. distributions, of products discovered/developed by the Company.
Footnote F2
On February 24, 2021, the reporting person was granted performance-based stock units (PSUs) in connection with the issuer 2020 year-end compensation review. The PSUs vest in separate installments based on the achievement of four specified performance measures as determined by the People, Culture and Compensation Committee of the issuer Board of Directors. The shares reported were issued to the reporting person upon vesting of one-quarter of the PSUs based on achievement of a corresponding performance measure relating to the issuer public reporting of the achievement of the first $2.5 billion in cumulative net product revenues determined in accordance with GAAP based solely upon the sales by the Company, including its affiliates and ex-U.S. distributions, of products discovered/developed by the Company.
Footnote F3
Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.
Footnote F4
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $184.01 to $185.01. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Footnote F5
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $185.02 to $186.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Footnote F6
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $186.03 to $187.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Footnote F7
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $187.04 to $188.04. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Footnote F8
Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting event.
Footnote F9
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $188.14 to $189.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Footnote F10
Reflects shares of ALNY common stock acquired by the reporting person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.